Amit Pande

756 total citations
27 papers, 234 citations indexed

About

Amit Pande is a scholar working on Surgery, Transplantation and Oncology. According to data from OpenAlex, Amit Pande has authored 27 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Transplantation and 8 papers in Oncology. Recurrent topics in Amit Pande's work include Renal Transplantation Outcomes and Treatments (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Fibroblast Growth Factor Research (5 papers). Amit Pande is often cited by papers focused on Renal Transplantation Outcomes and Treatments (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Fibroblast Growth Factor Research (5 papers). Amit Pande collaborates with scholars based in United States, India and Spain. Amit Pande's co-authors include Teresa Macarulla, Lipika Goyal, Ghassan K. Abou‐Alfa, Milind Javle, Saeed Sadeghi, Sameek Roychowdhury, Ivan Borbath, Ritesh Sachdev, Simmi Mehra and Do‐Youn Oh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Amit Pande

25 papers receiving 227 citations

Peers

Amit Pande
Alwin Hwai Liang Loh Singapore
Anne-Cécile Métivier France
Hironao Okubo Japan
Vatche Tchekmedyian United States
Eric Beohou France
Kathy Dominy United Kingdom
Keisuke Minamimura Japan
Thatcher Heumann United States
Giorgio Papiani Italy
Ozan Salim Türkiye
Alwin Hwai Liang Loh Singapore
Amit Pande
Citations per year, relative to Amit Pande Amit Pande (= 1×) peers Alwin Hwai Liang Loh

Countries citing papers authored by Amit Pande

Since Specialization
Citations

This map shows the geographic impact of Amit Pande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Pande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Pande more than expected).

Fields of papers citing papers by Amit Pande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Pande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Pande. The network helps show where Amit Pande may publish in the future.

Co-authorship network of co-authors of Amit Pande

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Pande. A scholar is included among the top collaborators of Amit Pande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Pande. Amit Pande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pandey, Prashant, et al.. (2023). Detection of donor-specific HLA antibodies: A retrospective observation in 350 renal transplant cases. Transplant Immunology. 77. 101783–101783. 1 indexed citations
3.
Pandey, Prashant, et al.. (2022). Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases. Transplant Immunology. 75. 101680–101680. 8 indexed citations
4.
Pandey, Prashant, et al.. (2021). From hesitancy to certainty: A case of successful desensitization in high risk HLA incompatible kidney transplantation. Indian Journal of Nephrology. 31(3). 324–324. 1 indexed citations
5.
Javle, Milind, Robin Kate Kelley, Christoph Springfeld, et al.. (2021). A phase II study of infigratinib in previously treated advanced/metastatic cholangiocarcinoma with FGFR gene fusions/alterations.. Journal of Clinical Oncology. 39(3_suppl). TPS356–TPS356. 3 indexed citations
6.
Abou‐Alfa, Ghassan K., Ivan Borbath, Allen Lee Cohn, et al.. (2020). 1014TiP PROOF: A multicenter, open-label, randomized, phase III trial of infigratinib vs gemcitabine + cisplatin in patients with advanced cholangiocarcinoma with FGFR2 gene rearrangements. Annals of Oncology. 31. S701–S702. 1 indexed citations
7.
Javle, Milind, Saeed Sadeghi, Sameek Roychowdhury, et al.. (2020). SO-5 Efficacy of second-line chemotherapy in patients with advanced or metastatic cholangiocarcinoma and FGFR2 fusions: A retrospective analysis. Annals of Oncology. 31. S219–S219. 2 indexed citations
8.
Abou‐Alfa, Ghassan K., Ivan Borbath, Lipika Goyal, et al.. (2020). P-144 Infigratinib versus gemcitabine plus cisplatin as first-line therapy in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: phase 3 PROOF trial. Annals of Oncology. 31. S136–S137. 2 indexed citations
9.
Makawita, Shalini, Ghassan K. Abou‐Alfa, Sameek Roychowdhury, et al.. (2020). Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. Future Oncology. 16(30). 2375–2384. 72 indexed citations
10.
Pandey, Prashant, et al.. (2020). Comparative Study for Measurement of Residual Leucocytes in Leucodepleted Red Blood Cells by Two Different Methods. Indian Journal of Hematology and Blood Transfusion. 36(4). 740–744. 1 indexed citations
11.
12.
13.
Pandey, Prashant, et al.. (2019). Renal transplantation in HLA sensitized patients: Traversing the immunological barrier. Therapeutic Apheresis and Dialysis. 24(5). 578–590. 4 indexed citations
14.
Pande, Amit, et al.. (2017). Detection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory. Asian Journal of Transfusion Science. 11(2). 171–171. 2 indexed citations
15.
Pande, Amit, et al.. (2016). Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia. Indian Journal of Pathology and Microbiology. 59(3). 310–310. 11 indexed citations
16.
Gajendra, Smeeta, et al.. (2016). CD5 positive hairy cell leukemia: A rare case report with brief review of literature. Cytometry Part B Clinical Cytometry. 90(5). 467–472. 20 indexed citations
17.
Mehra, Simmi, et al.. (2015). Stability of eosin-5'-maleimide dye used in flow cytometric analysis for red cell membrane disorders. Blood Research. 50(2). 109–109. 3 indexed citations
18.
19.
Sachdev, Ritesh, et al.. (2014). Primary Follicular Lymphoma of the Breast: A Rare Clinical Entity Diagnosed Using Tissue Flow Cytometry. Indian Journal of Hematology and Blood Transfusion. 31(2). 300–301. 2 indexed citations
20.
Pande, Amit, et al.. (2012). Anemia in Antiretroviral Naïve HIV/AIDS Patients: A Study from Eastern India. SHILAP Revista de lepidopterología. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alwin Hwai Liang Loh Breakdown of academic impact, for papers by Anne-Cécile Métivier Breakdown of academic impact, for papers by Hironao Okubo Breakdown of academic impact, for papers by Vatche Tchekmedyian Breakdown of academic impact, for papers by Eric Beohou Breakdown of academic impact, for papers by Kathy Dominy Breakdown of academic impact, for papers by Keisuke Minamimura Breakdown of academic impact, for papers by Thatcher Heumann Breakdown of academic impact, for papers by Giorgio Papiani Breakdown of academic impact, for papers by Ozan Salim
Rankless by CCL
2026